Stocks and Investing Stocks and Investing
Fri, March 8, 2024

Graig Suvannavejh Reiterated (AMLX) at Strong Buy with Increased Target to $32 on, Mar 8th, 2024


Published on 2024-10-28 09:34:25 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Increased Target from $27 to $32 on, Mar 8th, 2024.

Graig has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 0 agree with Graig's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Graig


  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $37 on, Wednesday, January 3rd, 2024
  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $36 on, Tuesday, December 12th, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Friday, November 10th, 2023
  • Chris Shibutani of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 10th, 2023
Contributing Sources